{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T15:54:30Z","timestamp":1649087670250},"reference-count":20,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2013,5,20]],"date-time":"2013-05-20T00:00:00Z","timestamp":1369008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics and Practice"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is a slowly progressive chronic disease, with a high prevalence among obese, dyslipidemic or diabetic people, commonly presented as an asymptomatic mild elevation of serum aminotransferases. We report a patient who experienced an acute form of non-alcoholic steatohepatitis, as the first manifestation of NAFLD, due to exacerbation of pre-existing metabolic disorders by an extremely unhealthy lifestyle. A 50-year old, obese, diabetic man presented with a one-week history of jaundice and malaise. Analysis revealed elevated liver enzymes, bilirubin, lipids, and glucose. Based on patient\u2019s history, physical examination, laboratory results, and imaging findings, acute non-alcoholic steatohepatitis was established as a diagnosis of exclusion. The patient was started on a low-calorie diet free of carbohydrates and fats, in combination with insulin. A dramatic improvement of clinical and laboratory parameters was observed. In the context of extreme metabolic dysregulation, induced by unhealthy diet, NAFLD may present as an acute steatohepatitis.<\/jats:p>","DOI":"10.4081\/cp.2013.e17","type":"journal-article","created":{"date-parts":[[2013,5,20]],"date-time":"2013-05-20T09:32:26Z","timestamp":1369042346000},"page":"e17","source":"Crossref","is-referenced-by-count":1,"title":["Acute Steatohepatitis, Due to Extreme Metabolic Dysregulation, as the First Presentation of Non-Alcoholic Fatty Liver Disease"],"prefix":"10.3390","volume":"3","author":[{"given":"Georgios","family":"Kranidiotis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angeliki","family":"Angelidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouel","family":"Sevdalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas-Nikolaos","family":"Telios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Gougoutsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Melidonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2013,5,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.bpg.2010.08.005","article-title":"Nonalcoholic fatty liver disease","volume":"24","author":"Krawczyk","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000282080","article-title":"Epidemiology of non-alcoholic fatty liver disease","volume":"28","author":"Bellentani","year":"2010","journal-title":"Dig Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1440-1746.2010.06253.x","article-title":"A fresh look at NASH pathogenesis. Part 1: the metabolic movers","volume":"25","author":"Larter","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1590\/S0004-28032012000100015","article-title":"Metabolic syndrome and risk factors for non-alcoholic fatty liver disease","volume":"49","author":"Souza","year":"2012","journal-title":"Arq Gastroenterol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2036.2010.04556.x","article-title":"Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"33","author":"Dowman","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/01.CIR.31.3.321","article-title":"A system for phenotyping hyperlipoproteinemia","volume":"31","author":"Fredrickson","year":"1965","journal-title":"Circula tion"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2036.2007.03586.x","article-title":"Adipokines and cytokines in non-alcoholic fatty liver disease","volume":"27","author":"Jarrar","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1111\/j.1572-0241.2007.01322.x","article-title":"Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis","volume":"102","author":"Shimada","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1572-0241.2007.01774.x","article-title":"Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis","volume":"103","author":"Wieckowska","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/hep.23050","article-title":"Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study","volume":"50","author":"Feldstein","year":"2009","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0884533611419668","article-title":"Nonalcoholic fatty liver disease: a review of the spectrum of disease, diagnosis, and therapy","volume":"26","author":"Kopec","year":"2011","journal-title":"Nutr Clin Pract"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/jmri.21542","article-title":"Magnetic resonance imaging and spectroscopy for monitoring liver steatosis","volume":"28","author":"Cowin","year":"2008","journal-title":"J Magn Reson Imaging"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1572-0241.2002.05644.x","article-title":"Acute severe steatohepatitis related to prednisolone therapy","volume":"97","author":"Dourakis","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejim.2004.10.018","article-title":"Acute hepatitis related to prednisolone","volume":"16","author":"Hofstee","year":"2005","journal-title":"Eur J Intern Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1111\/j.1572-0241.1999.03379.x","article-title":"Subacute severe steatohepatitis during prednisolone therapy for systemic lupus erythematosis","volume":"94","author":"Nanki","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/j.1572-0241.2002.05922.x","article-title":"Subacute liver failure in obese women","volume":"97","author":"Caldwell","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00125-011-2446-4","article-title":"Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials","volume":"55","author":"Musso","year":"2012","journal-title":"Diabetologia"}],"container-title":["Clinics and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2039-7283\/3\/2\/e17\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T06:22:31Z","timestamp":1644474151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2039-7283\/3\/2\/e17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,20]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,5]]}},"alternative-id":["cp.2013.e17"],"URL":"https:\/\/doi.org\/10.4081\/cp.2013.e17","relation":{},"ISSN":["2039-7283"],"issn-type":[{"value":"2039-7283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,20]]}}}